%0 Journal Article
%A Tramsen, Lars
%A Bochennek, Konrad
%A Sparber-Sauer, Monika
%A Salzmann-Manrique, Emilia
%A Scheer, Monika
%A Dantonello, Tobias
%A Borkhardt, Arndt
%A Dirksen, Uta
%A Thorwarth, Anne
%A Greiner, Jeanette
%A Ebinger, Martin
%A Weclawek-Tompol, Jadwiga
%A Ladenstein, Ruth
%A Ljungman, Gustaf
%A Hallmen, Erika
%A Lehrnbecher, Thomas
%A Koscielniak, Ewa
%A Klingebiel, Thomas
%T Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials.
%J Cancers
%V 15
%N 7
%@ 2072-6694
%C Basel
%I MDPI
%M DKFZ-2023-00769
%P 2050
%D 2023
%X Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma (STS) in childhood. Whereas more than 90
%K children (Other)
%K long-term maintenance therapy (Other)
%K metastatic (Other)
%K outcome (Other)
%K rhabdomyosarcoma (Other)
%K soft tissue sarcoma (Other)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:37046711
%2 pmc:PMC10093505
%R 10.3390/cancers15072050
%U https://inrepo02.dkfz.de/record/275449